Skip to main content

Table 1 Baseline characteristics of cases and matched controls for NEC (matching factors highlighted)

From: Application of the matched nested case-control design to the secondary analysis of trial data

 

Cases

(severe NEC)

(n = 35)

Matched controls

(n = 140)a

Non-cases

(n = 363)

Allocated to early arm, n (%)

17 (48.6)

74 (52.9)

182 (50.1)

Male sex, n (%)

20 (57.1)

80 (57.1)

193 (53.2)

Gestational age (weeks)

 Median (IQR)

29 (27 to 31)

29 (28 to 31)

32 (29 to 33)

  < 29 weeks

16 (45.7)

61 (43.6)

69 (19.0)

  > =29 weeks

19 (54.3)

79 (56.4)

294 (81.0)

Birth weight (grams)

 Median (IQR)

750 (660 to 931)

780 (695 to 890)

1030 (810 to 1280)

  < 750 g

17 (48.6)

53 (37.9)

57 (15.7)

  > =750 g

18 (51.4)

87 (62.1)

306 (84.3)

Multiple pregnancy, n (%)

 Twins

5 (14.3)

26 (18.6)

83 (22.9)

 Triplets

0

3 (2.1)

6 (1.7)

Pregnancy induced hypertension, n (%)

13 (37.1)

69 (49.3)

145 (40.1)

 Missing

0

0

1

Absent/reversed doppler abnormality, n(%)

35 (100.0)

138 (98.6)

347 (95.6)

Given antenatal steroids, n (%)

34 (97.1)

132 (95.7)

331 (91.4)

 Missing

0

2

1

Onset of delivery, n (%)

 Spontaneous

2 (5.7)

2 (1.4)

7 (1.9)

 Induced

0

1 (0.7)

4 (1.1)

 Caesarean

33 (94.3)

137 (97.9)

352 (97.0)

Apgar score at 5 min

 Median (IQR)

9 (8 to 9)

9 (8 to 10)

9 (9 to 10)

 Missing

2

2

7

Ventilated at trial entry, n (%)

2 (5.7)

30 (21.4)

45 (12.4)

CPAPb at trial entry, n (%)

22 (62.9)

78 (55.7)

122 (33.6)

UACc in situ at trial entry, n (%)

11 (31.4)

35 (25.0)

44 (12.1)

UVCd in situ at trial entry, n (%)

19 (54.3)

67 (48.6)

92 (25.4)

 Missing

0

2

1

Any diagnosis of severe NECe

35 (100.0)

8 (5.7)

0

  1. a109 unique controls. Each case is matched to 4 controls with the same sex and the smallest distance in terms of the Mahalanobis distance based on gestational age and birth weight. For cases where the difference is the same, infants are selected at random. bContinuous Positive Airway Pressure. cUmbilical artery catheter. dUmbilical venous catheter. eMatched controls can include infants who develop severe necrotising enterocolitis at some time in the future